Business Context and Reporting Period
This Form 8-K is a current report filed by AgeX Therapeutics, Inc. (trading symbol: AGE) on December 21, 2023. The registrant is a Delaware corporation headquartered in Alameda, California, and is classified as an emerging growth company. The filing discloses the execution of indemnification agreements related to a specific share transfer event.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on a legal obligation regarding a share transfer rather than periodic financial performance.
Material Changes and Events
- Share Transfer: A transfer of 16,447,500 shares of AgeX common stock occurred from Juvenescence US Corp. to JuvVentures (UK) Limited.
- Indemnification Obligations: AgeX executed a Letter of Indemnification to protect Equiniti Trust Company LLC (the transfer agent) against claims arising from the share transfer.
- Counter-Indemnification: Juvenescence Limited, the ultimate parent of the transferring and receiving entities, agreed to indemnify AgeX against any claims or losses resulting from the share transfer or the indemnity provided to Equiniti.
Guidance, Outlook, and Risks
The filing contains no financial guidance, operational outlook, or management commentary regarding future business performance. It includes a standard disclaimer regarding forward-looking statements, noting that actual results may differ materially from anticipated results due to risk factors detailed in other SEC filings. The primary contingency disclosed is the potential for claims or liabilities arising from the share transfer, which are now subject to the indemnification agreements described.
Investor Verification Checklist
- Verify the ownership structure and relationship between Juvenescence US Corp., JuvVentures (UK) Limited, and Juvenescence Limited.
- Confirm the impact of the 16,447,500 share transfer on the company's total outstanding share count and major shareholder composition.
- Review the full text of the "Letter of Indemnification" and the "Transfer of Shares... Indemnification Agreement" (Exhibits) to understand the scope of liabilities.
- Check subsequent filings for any actual claims made against AgeX or Equiniti Trust Company LLC related to this transfer.